Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
| 394 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//SHIKONIN | 32432 |
| 846 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 11845 |
| 35919 | 1 | MENOGARIL//DNA UNWINDING ACTIVITY//INOVACENTRUM | 105 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | MENOGARIL | authKW | 3771598 | 16% | 74% | 17 |
| 2 | DNA UNWINDING ACTIVITY | authKW | 300163 | 1% | 100% | 1 |
| 3 | INOVACENTRUM | address | 300163 | 1% | 100% | 1 |
| 4 | KATEDRA HYG | address | 300163 | 1% | 100% | 1 |
| 5 | PHASE II AML | authKW | 300163 | 1% | 100% | 1 |
| 6 | PHASE II MENOGARIL ASTROCYTOMA | authKW | 300163 | 1% | 100% | 1 |
| 7 | ILLINOIS CANC | address | 100053 | 1% | 33% | 1 |
| 8 | STOMACH CANCERS | authKW | 100053 | 1% | 33% | 1 |
| 9 | USTAV PLYNARENSTVI KOKSOCHEM OCHRANY OVZDUSI | address | 42879 | 1% | 14% | 1 |
| 10 | INVESTIGATIONAL NEW DRUGS | journal | 29648 | 15% | 1% | 16 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 1476 | 61% | 0% | 64 |
| 2 | Pharmacology & Pharmacy | 284 | 31% | 0% | 33 |
| 3 | Biophysics | 90 | 11% | 0% | 12 |
| 4 | CYTOLOGY & HISTOLOGY | 38 | 1% | 0% | 1 |
| 5 | Toxicology | 19 | 5% | 0% | 5 |
| 6 | Biochemistry & Molecular Biology | 15 | 14% | 0% | 15 |
| 7 | Biology | 6 | 3% | 0% | 3 |
| 8 | Chemistry, Medicinal | 5 | 3% | 0% | 3 |
| 9 | Multidisciplinary Sciences | 2 | 1% | 0% | 1 |
| 10 | Chemistry, Multidisciplinary | 0 | 5% | 0% | 5 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INOVACENTRUM | 300163 | 1% | 100% | 1 |
| 2 | KATEDRA HYG | 300163 | 1% | 100% | 1 |
| 3 | ILLINOIS CANC | 100053 | 1% | 33% | 1 |
| 4 | USTAV PLYNARENSTVI KOKSOCHEM OCHRANY OVZDUSI | 42879 | 1% | 14% | 1 |
| 5 | FAK VOJENSKEHO ZDRAVOTNICTVI | 13049 | 1% | 4% | 1 |
| 6 | CHEM BIODYNAM | 6251 | 1% | 2% | 1 |
| 7 | KATEDRA CHEM | 4412 | 1% | 1% | 1 |
| 8 | OPERAT OFF | 2255 | 1% | 1% | 1 |
| 9 | ROBERT H LURIE CANC | 1315 | 1% | 0% | 1 |
| 10 | PRIRODOVEDECKA FAK | 844 | 1% | 0% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INVESTIGATIONAL NEW DRUGS | 29648 | 15% | 1% | 16 |
| 2 | SELECTIVE CANCER THERAPEUTICS | 4919 | 1% | 2% | 1 |
| 3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 3982 | 5% | 0% | 5 |
| 4 | CANCER TREATMENT REPORTS | 3401 | 5% | 0% | 5 |
| 5 | INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS | 1848 | 4% | 0% | 4 |
| 6 | CHEMICO-BIOLOGICAL INTERACTIONS | 1288 | 5% | 0% | 5 |
| 7 | CANCER RESEARCH | 1285 | 12% | 0% | 13 |
| 8 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1171 | 4% | 0% | 4 |
| 9 | BASIC AND APPLIED HISTOCHEMISTRY | 876 | 1% | 0% | 1 |
| 10 | ANTIBIOTIKI I MEDITSINSKAYA BIOTEKHNOLOGIYA | 774 | 1% | 0% | 1 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MENOGARIL | 3771598 | 16% | 74% | 17 | Search MENOGARIL | Search MENOGARIL |
| 2 | DNA UNWINDING ACTIVITY | 300163 | 1% | 100% | 1 | Search DNA+UNWINDING+ACTIVITY | Search DNA+UNWINDING+ACTIVITY |
| 3 | PHASE II AML | 300163 | 1% | 100% | 1 | Search PHASE+II+AML | Search PHASE+II+AML |
| 4 | PHASE II MENOGARIL ASTROCYTOMA | 300163 | 1% | 100% | 1 | Search PHASE+II+MENOGARIL+ASTROCYTOMA | Search PHASE+II+MENOGARIL+ASTROCYTOMA |
| 5 | STOMACH CANCERS | 100053 | 1% | 33% | 1 | Search STOMACH+CANCERS | Search STOMACH+CANCERS |
| 6 | SOUTHWEST ONCOLOGY GROUP | 23088 | 1% | 8% | 1 | Search SOUTHWEST+ONCOLOGY+GROUP | Search SOUTHWEST+ONCOLOGY+GROUP |
| 7 | HYPERNEPHROMA | 8826 | 1% | 3% | 1 | Search HYPERNEPHROMA | Search HYPERNEPHROMA |
| 8 | CLEAVABLE COMPLEX | 8574 | 1% | 3% | 1 | Search CLEAVABLE+COMPLEX | Search CLEAVABLE+COMPLEX |
| 9 | PHASE II | 5212 | 4% | 0% | 4 | Search PHASE+II | Search PHASE+II |
| 10 | ANTITUMOR EFFECTS | 3614 | 1% | 1% | 1 | Search ANTITUMOR+EFFECTS | Search ANTITUMOR+EFFECTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |